Ichikawa, Japan

Takao Nagahama


Average Co-Inventor Count = 6.8

ph-index = 3

Forward Citations = 31(Granted Patents)


Location History:

  • Shiga, JP (1997)
  • Otsu, JP (2001)
  • Ichikawa, JP (2003)

Company Filing History:


Years Active: 1997-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Takao Nagahama

Introduction

Takao Nagahama is a notable inventor based in Ichikawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly focusing on compounds that address serious health issues such as fibrosis. With a total of three patents to his name, his innovations are pivotal in advancing medical treatments.

Latest Patents

Among his latest patents, Takao Nagahama developed a pyridine derivative and a pharmaceutical containing the same. This pyridine derivative, represented by a specific formula defined in the patent specification, plays a crucial role in inhibiting collagen production, a key factor in the prevention and treatment of fibrosis. In addition, he holds a patent for a novel pyrimidine derivative represented by another general formula, which reflects his ongoing commitment to medical innovation.

Career Highlights

Currently, Takao Nagahama is affiliated with Otsuka Pharmaceutical Company, Limited, a leading organization in the pharmaceutical industry. His work focuses on developing new therapeutic solutions that can significantly improve patient outcomes. His dedicated approach to research and application has made him a respected figure in his field.

Collaborations

Throughout his career, Takao has collaborated with esteemed colleagues such as Koichi Yasumura and Shintaro Ishikawa. These partnerships have enhanced his research capabilities and contributed to the development of innovative pharmaceutical solutions.

Conclusion

In summary, Takao Nagahama's expertise in the field of pharmaceuticals and his dedication to innovation have led to significant advancements in treating fibrosis and other health conditions. With his ongoing research and patents, he continues to inspire the medical community and drive forward the potential for new treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…